Wood smoke exposure and risk of chronic obstructive pulmonary disease

It was hypothesised that wood smoke exposure could be a risk factor for chronic obstructive pulmonary disease (COPD) in Spain. The present study was designed as a case–control study of 120 females requiring hospitalisation during 2001–2003 at Hospital del Mar (Barcelona, Spain). Cases were recruited from hospital records as females who had been admitted for an exacerbation of COPD. Controls were obtained from pulmonary function test laboratory consultations prior to a surgical intervention. All patients answered a standardised questionnaire. Exposure to wood or charcoal smoke was strongly associated with COPD after adjusting for age and smoking. The association between length of exposure and COPD suggested a dose–response pattern. Intensity of exposure in both summer and winter was also related to COPD. Wood or charcoal alone independently increased risk of COPD (odds ratio (OR) 1.8 and 1.5, respectively), but only the combination of both was statistically significant (OR 4.5). In conclusion, the present study shows a strong association between wood or charcoal smoke exposure and chronic obstructive pulmonary disease, supporting its existence not only in developing countries, but also in European countries, such as Spain. Further studies assessing whether this association also exists in other European societies are warranted.

[1]  Kirk R. Smith,et al.  Air pollution and rural biomass fuels in developing countries: A pilot village study in India and implications for research and policy☆ , 1983 .

[2]  M. Miravitlles,et al.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.

[3]  J. Barberà,et al.  [Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]. , 2001, Archivos de bronconeumologia.

[4]  M. Jeng,et al.  Effects of exogenous surfactant supplementation and partial liquid ventilation on acute lung injury induced by wood smoke inhalation in newborn piglets , 2003, Critical care medicine.

[5]  M. Kramer,et al.  Clinical Epidemiology and Biostatistics , 1988, Springer Berlin Heidelberg.

[6]  Sandra A. Norman,et al.  Clinical Investigations: EnvironmentWoodsmoke Exposure and Risk for Obstructive Airways Disease Among Women , 1996 .

[7]  J. Sandoval,et al.  Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. , 1993, Chest.

[8]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[9]  B. Burrows,et al.  Pulmonary terms and symbols. A report of the ACCP-STS Joint Committee on Pulmonary Nomenclature. , 1975, Chest.

[10]  R. Sansores,et al.  Matrix metalloproteinases activity in COPD associated with wood smoke. , 2004, Chest.

[11]  D. Maldonado,et al.  Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.

[12]  John Wilson Pulmonary Function Tests in Clinical and Occupational Lung Disease , 1989 .

[13]  Bengt G Järvholm,et al.  Adverse health effects from ambient air pollution in relation to residential wood combustion in modern society. , 2003, Scandinavian journal of work, environment & health.

[14]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[15]  Y. Kou,et al.  Alleviation of wood smoke-induced lung injury by tachykinin receptor antagonist and hydroxyl radical scavenger in guinea pigs. , 2001, European journal of pharmacology.

[16]  W. Ahrens,et al.  Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  A. Agustí,et al.  Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica , 2001 .

[18]  D. Barker Rise and fall of Western diseases , 1989, Nature.

[19]  J. Garcia-Aymerich,et al.  Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). , 2000, The European respiratory journal.

[20]  M. Green Air pollution and health , 1995 .

[21]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.